Freda Lewis-Hall - Apr 22, 2024 Form 4 Insider Report for CONDUIT PHARMACEUTICALS INC. (CDT)

Role
Director
Signature
/s/ Freda Lewis-Hall
Stock symbol
CDT
Transactions as of
Apr 22, 2024
Transactions value $
$0
Form type
4
Date filed
4/24/2024, 05:00 PM
Previous filing
Mar 28, 2024
Next filing
May 17, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDT Warrant (Right to buy) Award +401K 401K Apr 22, 2024 Common Stock 401K $3.12 Intelmed LLC F1, F2
transaction CDT Warrant (Right to buy) Award +103K 103K Apr 22, 2024 Common Stock 103K $3.12 Emerson Hall F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Warrants issued in exchange for one year lock-up of reporting person's common stock of the company, par value $0.0001 per share, and the payment of $0.125 per warrant.
F2 The Shares are held of record by Intelmed LLC ("Intelmed"). Ms. Lewis-Hall is the Managing Director of Intelmed and in such capacity has voting and investment discretion with respect to the Shares held of record by Intelmed. By virtue of this relationship, Ms. Lewis-Hall may be deemed to share beneficial ownership of the Shares held of record by Intelmed. Ms. Lewis-Hall disclaims any such beneficial ownership except to the extent of her pecuniary interest therein.
F3 Such Shares are held by Ms. Lewis-Hall's spouse, Mr. Emerson Hall, Jr. As Mr. Hall's spouse and by virtue of their relationship, Ms. Lewis-Hall may be deemed to share beneficial ownership of such shares held by record by Mr. Emerson Hall, Jr. Ms. Lewis-Hall disclaims any such beneficial ownership except to the extent of her pecuniary interest therein.